Chiron to Boost Flu Vaccine Production 25%
- Share via
Chiron Corp., the world’s second-biggest maker of influenza shots, will boost production of its Fluvirin vaccine by about 25% next year, Chief Executive Howard Pien said.
Pien, speaking at the J.P. Morgan Healthcare Conference in San Francisco, also said the board approved a request to spend $100 million to update its vaccine-manufacturing facilities. The company will make about 50 million doses of the vaccine next year, up from more than 40 million this year, the company said.
Shares of Emeryville, Calif.-based Chiron fell 36 cents to $51.14 on Nasdaq.
From Bloomberg News
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
